Global Biologics Contract Manufacturing Market Set to Reach $83.47 Billion by 2033 Driven by Rising Biologics Demand, Technological Advancements, and Strategic Outsourcing | Wuxi Biologics, AGC Biologics, Lonza

Biologics Contract Manufacturing Market reached US$ 26.03 billion in 2024 and is expected to reach US$ 83.47 billion by 2033, growing at a CAGR of 14.0% during the forecast period 2025-2033.

The Biologics Contract Manufacturing market involves outsourcing the production of complex biologic drugs, including vaccines, antibodies, and recombinant proteins. Rising demand for biologics, cost-effective manufacturing, and scalable production drives growth. Technological advancements in cell culture, purification, and quality control enhance capabilities. Pharmaceutical partnerships and outsourcing strategies further support market expansion. Regulatory compliance and increasing global biologics adoption accelerate growth.

📌 Download Sample Report to Identify Emerging Deals & Opportunities in the Biologics Contract Manufacturing Market Landscape:- https://datamintelligence.com/download-sample/biologics-contract-manufacturing-market?rk

☛ Biologics Contract Manufacturing Market Recent Developments 2025:

United States: Recent Industry Developments

✅ In October 2024, Samsung Biologics secured a $1.2 billion contract with an unnamed Asian pharmaceutical company, extending through December 2037. This deal brings the company's total 2024 contract value to over $3.3 billion.

✅ In July 2024, BeiGene inaugurated its $800 million biologics manufacturing and R&D facility in Hopewell, New Jersey. The 400,000-square-foot site is designed to scale production for oncology treatments and is expected to create hundreds of new jobs.

✅ In January 2024, AbbVie announced a $223 million expansion of its Singapore manufacturing facility. The expansion will add 24,000 liters of biologics drug-substance capacity to support its immunology and oncology pipeline.

Japan: Recent Industry Developments

✅ In January 2024, AGC Biologics announced plans for a new 20,000 m2 manufacturing site in Yokohama, Japan. The facility will feature mammalian cell culture, messenger RNA, and cell therapy services, with operations expected to commence in 2026.

✅ In April 2025, AGC Biologics strengthened its single-use technology network by adding two 5,000 L Thermo Scientific DynaDrive Single-Use Bioreactors to its new Yokohama facility. This move aims to enhance large-scale GMP manufacturing capabilities.

✅ In April 2024, AGC Biologics collaborated with Cytiva to innovate its production line at the Yokohama facility using two FlexFactory manufacturing platforms. This partnership is set to enhance the facility's production capabilities.

☛ Biologics Contract Manufacturing Market Competitve Landscape:

Wuxi Biologics, AGC Biologics, Lonza, FUJIFILM Diosynth Biotechnologies, Thermo Fisher Scientific Inc., KBI Biopharma, Vetter Pharma, Recipharm AB., Abzena Ltd, Samsung Biologics, Eurofins CDMO, Catalent, Boehringer Ingelheim International GmbH.

Research Methodology

We follow a hybrid research approach, combining qualitative insights with rigorous quantitative analysis to deliver reliable and comprehensive market intelligence. Our process begins with extensive secondary research, drawing on trusted industry reports, proprietary databases, and credible market sources. This is then reinforced through targeted primary research, including structured surveys and in-depth interviews with industry leaders, subject matter experts, and key market participants.

📌 Request a Customized Market Report - Tailored insights to match your business goals: https://datamintelligence.com/customize/biologics-contract-manufacturing-market

☛ Segment Covered in the Biologics Contract Manufacturing Market:

Product Type: Monoclonal Antibodies | Recombinant Proteins | Cell and Gene Therapies | Vaccines | Others

Platform: Mammalian | Microbial | Others

Application: Oncology | Metabolic Diseases | Autoimmune Diseases | Ophthalmology | Infectious Diseases | Cardiovascular Diseases | Others

☛ This Report Includes:

✔ Comprehensive go-to-market strategies with actionable insights.

✔ Unbiased evaluation of overall market performance.

✔ Deep-dive analysis into development trends, competitive landscape, supply-demand dynamics, YoY growth, benchmarking, vendor mapping, market access, and overall progress.

✔ Tailored regional and country-level reports with detailed localized analysis available on request.

✔ Identification of niche segments and high-growth regions presenting strong opportunities.

✔ Accurate regional forecasts using both top-down and bottom-up approaches.

📌 Get Corporate Access to Live Biologics Contract Manufacturing Industry Intelligence Database: https://www.datamintelligence.com/buy-now-page?report=biologics-contract-manufacturing-market

☛ Regional Analysis for Biologics Contract Manufacturing Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

☛ Frequently asked questions:

➠ What is the global sales, production, consumption, import, and export value of the Biologics Contract Manufacturing Market?
➠ Who are the key global manufacturers, and what is their operational performance?
➠ What are the major opportunities and threats in the global Biologics Contract Manufacturing Market?
➠ Which product types or end-users show the most growth potential and market share?
➠ What challenges and constraints are impacting the Biologics Contract Manufacturing Market?
➠ What sales, marketing, and distribution channels are used globally?

📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.